Insider: YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO - REGENERON PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 818,093 | 180,000 | 998,093 |
| Value | $456,275,008.89 | $100,391,400.00 | $556,666,408.89 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 05/16/2024 | DDS | 4,669 | Direct | COM | $970.26 | $4,530,143.94 | 818,093 |
| 05/16/2024 | DDS | 4,922 | Direct | COM | $971.56 | $4,782,018.32 | 813,171 |
| 05/16/2024 | DDS | 9,501 | Direct | COM | $969.39 | $9,210,174.39 | 822,762 |
| 05/16/2024 | DDS | 3,213 | Direct | COM | $968.44 | $3,111,597.72 | 832,263 |
| 05/16/2024 | DDS | 379 | Direct | COM | $978.18 | $370,730.22 | 786,383 |
| 05/16/2024 | DDS | 790 | Direct | COM | $972.22 | $768,053.80 | 812,381 |
| 05/16/2024 | DDS | 907 | Direct | COM | $967.40 | $877,431.80 | 835,476 |
| 05/16/2024 | DDS | 2,653 | Direct | COM | $973.80 | $2,583,491.40 | 809,728 |
| 05/16/2024 | DDS | 4,886 | Direct | COM | $976.52 | $4,771,276.72 | 787,989 |
| 05/16/2024 | DDS | 1,227 | Direct | COM | $977.38 | $1,199,245.26 | 786,762 |
| 05/16/2024 | DDS | 7,611 | Direct | COM | $974.51 | $7,416,995.61 | 802,117 |
| 05/16/2024 | DDS | 9,242 | Direct | COM | $975.48 | $9,015,386.16 | 792,875 |
| 05/15/2024 | DDS | 406 | Direct | COM | $971.28 | $394,339.68 | 877,493 |
| 05/15/2024 | DDS | 784 | Direct | COM | $972.50 | $762,440.00 | 876,709 |
| 05/15/2024 | DDS | 4,778 | Direct | COM | $974.47 | $4,656,017.66 | 870,066 |
| 05/15/2024 | DDS | 5,225 | Direct | COM | $975.60 | $5,097,510.00 | 864,841 |
| 05/15/2024 | DDS | 846 | Direct | COM | $970.36 | $820,924.56 | 877,899 |
| 05/15/2024 | DDS | 1,865 | Direct | COM | $973.43 | $1,815,446.95 | 874,844 |
| 05/15/2024 | DDS | 1,428 | Direct | COM | $967.45 | $1,381,518.60 | 884,062 |
| 05/15/2024 | DDS | 6,885 | Direct | COM | $976.56 | $6,723,615.60 | 857,956 |
| 05/15/2024 | DDS | 111 | Direct | COM | $965.69 | $107,191.59 | 886,272 |
| 05/15/2024 | DDS | 782 | Direct | COM | $966.29 | $755,638.78 | 885,490 |
| 05/15/2024 | DDS | 3,387 | Direct | COM | $968.43 | $3,280,072.41 | 880,675 |
| 05/15/2024 | DDS | 1,930 | Direct | COM | $969.14 | $1,870,440.20 | 878,745 |
| 05/15/2024 | DDS | 4,865 | Direct | COM | $978.44 | $4,760,110.60 | 843,240 |
| 1 2 3 4 5 6 7 8 Next Last You are at page 1 of 8 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research